KLRS

Kalaris TherapeuticsB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

KLRS vs peer average

75/100

KLRS vs. peer average (B vs. D)

Grade spread

A 2 · B 1 · D 5 · F 3

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

ATRA is the first available peer comparator.

Loose small-cap biotech peer for financing sensitivity and binary clinical-event volatility, but not a close asset or indication match.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerATRAAtara Biotherapeutics

KLRS

Kalaris Therapeutics

ATRA

Atara Biotherapeutics

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs ATRA

KLRS / ATRA

Grade Position

Above peers

KLRS vs. peer average (B vs. D)

75/100

Momentum

ATRA

Value

ATRA

Sentiment

KLRS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs KLRS

ATRA

100/100

-1

BDTX

100/100

-1

SEER

20/100

VRCA

Verrica Pharmaceuticals Inc Common

40/100

RANI

Rani Therapeutics Holdings Inc Class A Common

80/100

Even

ATRA is the first peer returned for this comparison set.